Microarray analyses have contributed greatly to the rapid understanding of functional genomics through the identification of gene networks as well as gene discovery. To facilitate functional genomics of the inner ear, we have developed a mouse inner-earpertinent custom microarray chip (CMA-IE1). Nonredundant cDNA clones were obtained from two cDNA library resources: the RIKEN subtracted inner ear set and the NIH organ of Corti library. At least 2000 cDNAs unique to the inner ear were present on the chip. Comparisons were performed to examine the relative expression levels of these unique cDNAs within the organ of Corti, lateral wall, and spiral ganglion. Total RNA samples were obtained from the three cochlear-dissected fractions from adult CF-1 mice. The total RNA was linearly amplified, and a dendrimer-based system was utilized to enhance the hybridization signal. Differentially expressed genes were verified by comparison to known gene expression patterns in the cochlea or by correlation with genes and gene families deduced to be present in the three tissue types. Approximately 22Y25% of the genes on the array had significant levels of expression. A number of differentially expressed genes were detected in each tissue fraction. These included genes with known functional roles, hypothetical genes, and various unknown or uncharacterized genes. Four of the differentially expressed genes found in the organ of Corti are linked to deafness loci. None of these are hypothetical or unknown genes.
INTRODUCTION
The majority of genes related to hearing loss can be classified into three major groups. In general, these are based on their functional roles, which are (1) stereocilia-based mechanoelectrical transduction, (2) K + recirculation and conductances, and (3) the compositional integrity and function of basement membranes. These genes are mainly expressed in the sensory epithelium, their surrounding supporting cells, or the cellular components of the cochlear lateral wall (composed primarily of the stria vascularis and spiral ligament). The set of genes that are involved in stereociliary development and homeostasis is suggested to comprise a network of interactive proteins, which include myosin VIIa, harmonin, cadherin 23, protocadherin 15, whirlin, and Sans (Boeda et al. 2002; Ahmed et al. 2003; Kikkawa et al. 2003; Mburu et al. 2003; Weil et al. 2003; Siemens et al. 2004 ). Many of the deafness genes initially appeared to be uniquely expressed in the inner ear, but subsequent data showed that their expression is not restricted to the inner ear. These genes are nonetheless pertinent for inner ear function . Hearing loss genes are grouped into syndromic and nonsyndromic forms based on the clinical manifestations of gene mutations. It is estimated that over 50% of the several hundred deafness loci are still unknown or uncharacterized. In the mouse, there exist at least 175 spontaneous or genetically manipulated hearing-impaired mutant lines carrying defective genes, with more being identified from the large-scale ENU-mutagenesis screen (Nolan et al. 2000; Kiernan et al. 2002; Rhodes et al. 2003) . Studies of these genes and their effects require techniques spanning from behavior to the analysis of unique cell types of the ear and their structureYfunction aspects. An essential strategy for such an analysis requires the examination of all genes expressed in the ear that are potentially affected and is exemplified by microarray technologies.
DNA microarray analysis does provide a means to study genes at a whole-genome level and can be used to (1) estimate expression levels, (2) begin characterizing previously unknown genes, (3) analyze differential gene expression among tissues, cells types, or specific treatments, (4) analyze mutational variations of a gene, and (5) identify gene interactions through clustering. Although limited in number, microarray studies of the inner ear have ranged from being more general discussions of utilization of these techniques and approaches for the investigation of the inner ear (Lomax et al. 2000; Chen and Corey 2002a,b) to more specific applications involving gene discovery, tissue comparison, and clustering analyses for gene network identification (Chen and Corey 2002a,b; Cho et al. 2002; Abe et al. 2003; Hawkins et al. 2003; Hertzano et al. 2004; Iijima et al. 2004 ). These studies demonstrate the general use and benefit of microarray analysis as an analytical tool for such analyses.
A common problem of all these studies is the lack of cDNAs or oligonucleotides exclusively representing inner ear transcripts. This impacts on the identification of genes involved in the development and function of the inner ear in both overabundance of uninformative genes as well as the absence of relevant genes. Another major difficulty in microarray assessment is the necessity of obtaining sufficient quantities of starting tissue for the generation of microarray probes. This requirement has mandated the use of whole inner ear/cochlear preparations, which can effectively Bdilute out[ the identification and quantification of pertinent transcripts. Recent technical advances in amplification of transcripts (Baugh et al. 2001; Badiee et al. 2003 ) and probe signal (Capaldi et al. 2000) have drastically reduced the required amount of starting material.
Recently, various cDNA libraries specific to the ear were constructed and analyzed Pompeia et al. 2004 ) as well as the mouse cDNA encyclopedia (Okazaki et al. 2002) . We constructed a cDNA microarray chip derived from cDNA libraries produced from the inner ear. Herein, we report the validation and utilization of this Binner-ear-pertinent[ cDNA microarray chip to identify the relative expression levels of known deafness genes and potential inner-ear-pertinent transcripts. Through the use of dissected fractions from the mouse cochlea representing the organ of Corti (OC), the lateral wall containing the stria vascularis (LW), and the spiral ganglion neurons (SG), differentially expressed genes were identified and their relationship to deafness loci was assessed.
MATERIALS AND METHODS

DNA preparation for printing
Bacteria cultures in 96-well plates were allowed to thaw at room temperature for approximately 30 min. Five microliters of each culture was added to a 96-well thin-wall PCR plate containing TE buffer (10 mM Tris, 1 mM EDTA). The plate was then heated to 95-C for 10 min, and an aliquot, 5 2l, of each supernatant was transferred to a fresh 96-well PCR plate and used to amplify the cDNA inserts.
Clone inserts were amplified in a Peltier thermal cycler (MJ Research, Inc., Waltham, MA) using a modified M13 primer set as described (Hegde et al. 2000) . Amplification was performed in 26 cycles with an annealing temperature of 55-C. The extension time was 6 min for the RIKEN inserts and 3 min for the NIH inserts. Following amplification, 5 2l of each sample was run out on a 1% agarose gel, which was used to determine the percentage of inserts that produced a product and the number of products with multiple PCR bands. The remainder of each sample was precipitated and then stored at 4-C until printing.
Slide preparation and printing
Dry PCR products were resuspended in sterile water (Sigma-Aldrich, Corp., St. Louis, MO), and 5 2l was transferred using a Biomek FX robot (Beckman Coulter, Inc., Fullerton, CA) into 384-well plates containing 5 2l DMSO (Sigma). The samples were printed in triplicate on Corning UltraGAPS slides with a Cartesian ProSys printer (Genomic Solutions, Ann Arbor, MI) and TeleChem Stealth pins (TeleChem International, Inc., Sunnyvale, CA). The relative humidity during the print was controlled at 40%. A total of 21,888 spots were printed (7296 unique spots) with a center to center distance of 200 2m. The printed arrays were then UV cross-linked at 250 mJ using a Stratalinker (Strategene) and stored in a desiccator at room temperature until used. An expiration date of 6 months was used for all microarray chips. 
Experimental design
RNA extraction
Tympanic bullae from four normal hearing Boutbred[ CF-1 male mice (4Y5 weeks) (Harlan, Indianapolis, IA) were dissected and immediately placed in cold Minimum Essential Medium (Invitrogen Corp., Carlsbad, CA) for fine dissection. Following removal of the temporal bone, the cochleae were dissected at 4-C to obtain large portions of the lateral wall (composed mostly of the stria vascularis and spiral ligament) and spiral ganglia and the whole OC, as represented in Figure 1 . The samples were placed in tubes containing RNA Later (Ambion, Inc., Austin, TX) and stored at j20-C. Note that tissue samples from different mice and from different cochlear regions were not combined. Rather, each sample was processed separately in all of the succeeding steps (RNA isolation, amplification, and probe generation).
For RNA isolation, tissue samples were transferred to lysis buffer, disrupted, and then homogenized using a QIAshredder column (QIAGEN Sciences, Inc., Germantown, MD). Total RNA was isolated using the Qiagen RNeasy Mini kit following the manufacturer_s standard protocol. DNase treatment was performed on the column as described in the manufacturer_s protocol. RNA integrity was verified using the Agilent 2100 Bioanalyzer with an RNA Pico Chip (Agilent Technologies, Palo Alto, CA) (see Figs. 2A and B) . RNA concentration was determined with a UV spectrophotometer and also estimated with the Bioanalyzer.
RNA amplification
Amplified RNA (aRNA) was synthesized using one round of a T7-based linear amplification protocol as described (Van Gelder et al. 1990; Baugh et al. 2001 ], 4 2l of 10 mM dNTPs, 20 U Escherichia coli DNA Polymerase I (Invitrogen), 10 U E. coli DNA Ligase (Invitrogen), and 2 U ribonuclease H (Invitrogen). The reaction was incubated at 16-C for 2 h. Afterwards, the cDNA was purified and concentrated using the DNAclear kit (Ambion).
In vitro transcription was performed using the MEGAscript T7 kit (Ambion) by adding NTPs, 10Â reaction buffer, and T7 enzyme to the purified cDNA. The resulting solution was incubated at 37-C for 14 h. Afterwards, the aRNA was purified using the RNeasy Mini Kit (QIAGEN). RNA integrity was verified, and the concentration was determined as described above (see Fig. 2C ). We were able to achieve greater than a thousand-fold amplification of the mRNA. Linear amplification of these samples was validated by their global expression data and comparing genes that are comparably expressed, such as housekeeping and ribosomal protein genes.
Probe synthesis, hybridization, and laser scanning A probe was generated for each of the 12 aRNA samples. A series of hybridizations was performed, with each probe being used in exactly two hybridization experiments as indicated in Table 1 . For probe generation and hybridizations, we used the 3DNA 350 RP Kit (Genisphere Inc., Hatfield, PA), which utilizes a dendrimer-based strategy to enhance the signal (Capaldi et al. 2000) . We followed the standard protocol for probe generation for a dual channel experiment, beginning with 200 ng of each aRNA sample. Briefly, RNA from each tissue was reversetranscribed into cDNA using unlabeled dNTPs. A capture sequence, which serves as the binding site for the fluorescent dendrimer, was ligated to the cDNA. The probes were combined and successive hybridizations were performed, first of the cDNA to the glass slide, then of the dendrimer mix to the cDNA. In both hybridization mixes, 3 2l Mouse Cot1 DNA (Invitrogen) was added, and 16 2g poly d(A) 40Y60 (Amersham Bioscience, Piscataway, NJ) was substituted for the dT blocker supplied in the kit. Both hybridizations were performed using the 2Â formamide-based hybridization buffer at 50-C. The hybridization times and posthybridization washes followed the recommendations in the protocol. Following hybridization, the slides were scanned with a GenePix 4000B laser scanner (Axon Instruments, Union City, CA) to determine the amount of each fluorescent cDNA that hybridized. Initial spot analysis and background subtraction were performed using the GenePix Pro 5.0 software (Axon Instruments).
Normalization and background subtraction
Background was calculated using a local feature background median, which was subtracted from each spot. Using this method, a background value is calculated for each feature individually based on the median intensity of pixels immediately surrounding the feature. A positive signal was defined as those spots with intensity levels greater than two standard deviations above background. The background-subtracted ratio of medians (635/532) was calculated for each spot. These data were then normalized using locally weighted print-tip normalization (Yang et al. 2002) to transform each ratio into a log value.
Data analysis
Log-transformed values from locally weighted normalization were input into the Significance Analysis of Microarrays (SAM) program (Tusher et al. 2001) .
Each comparison was input as a one class experiment, utilizing block permutations for the replicate spots on each chip. The delta value, which is used to set the cutoff point for significance, was adjusted to maximize the number of genes deemed significant while minimizing the number of false positives determined by the program. We found that there was a very narrow range for the delta value if we wanted to keep the number of false positives to a minimum.
RESULTS
Microarray characterization
Our mouse inner ear-pertinent custom microarray chip (designated CMA-IE1) is derived from the subtracted version of the RIKEN adult inner ear set (Unigene Library ID: 9974) and the NIH organ of Corti library (Unigene Library ID: 10920). As summarized in Table 2 , the array is composed of 5758 of the RIKEN clones and 1288 NIH clones, all spotted in triplicate. The majority of the NIH clones on the array consist of unknown or uncharacterized ESTs to facilitate gene discovery. Clones were also added, both from the NIH library and from our own collections that are involved in important auditory pathways. In addition, the array contains a number of controls (buffer, mouse Cot1, polyA) and spikes for the purposes of normalization and data analysis. We define spikes as genes added to the array from various species (e.g., Xenopus laevis, Anopheles gambiae, Schistosoma mansoni, and Apis mellifera) that have been shown not to hybridize to any known mouse transcript. Approximately 60 different spikes were added to the microarray chip. Spikes can serve as negative controls or included in the hybridization mix to quantify the sensitivity of the assay.
Depending on the comparison, around 22Y25% of the clones represented on the array showed positive signals greater than two standard deviations above background. This varied based on the cDNA source. Specifically, about 27Y31% of the clones from the NIH library were detected at this level compared with Not all the clones from the two libraries were represented on the microarray because the corresponding cDNA inserts could not be amplified using the combined rolling circle and PCR protocol of Hegde et al. (2000).
about 19Y24% of the RIKEN clones. For each comparison, the ratio of NIH to RIKEN clones detected was nearly the same. For the most part, we expected to see a fairly low level of detection. This is because the RIKEN inner ear set is highly subtracted and therefore consists of many genes expressed at low levels and/or only in specific tissues or cell types. The NIH organ of Corti unknown and/or uncharacterized cDNA clones ranged from being singletons to those which are moderately expressed. Singletons are defined as cDNAs that were isolated only once in a given cDNA library. In addition, we expect many genes from the NIH library to be detectable in the immature ear of postnatal mice (postnatal days 5Y13) and not in the adult cochlea because these cDNAs originate from mice at various developmental stages.
In general, low-frequency transcripts (~10Y25 copies/cell) were detected, whereas rare transcripts (G10 copies/cell) were not significantly above signal threshold to be classified as detectable. The limits of detection as defined by cellular transcript frequencies were ascertained by comparisons with the relative expression levels of housekeeping genes observed in reference control samples along with the clone frequency observed in the organ of Corti library . Because the organ of Corti library was not subtracted, the relative frequency of housekeeping and ribosomal protein transcripts within this library could also be inferred and compared with the corresponding cDNAs and their relative expression levels. One example of our microarray assay limit of detection is the observed expression of the nicotinic acetylcholine receptor a9 (Chrna9), which can be difficult to detect by in situ hybridization. Neither prestin nor Chrna10 was detected, and these genes are expressed at very low levels in the organ of Corti ( Judice et al. 2002) . This is consistent with microarray experiments in general. There is usually a cutoff point for detection that is dependent on many factors, including the number of copies of a gene present in the probe and the methods used for FIG. 3 . Utilization of genes specifying ribosomal proteins in normalization assessment. Intensity levels of a large set of genes specifying ribosomal proteins present on the array were examined. Data are for one of the organ of Corti versus spiral ganglion comparisons, but similar results were observed across all experiments. The ribosomal protein genes were categorized into high (91000 ESTs), moderate (9500 ESTs), and low (G250 ESTs) expression levels based on the number of ESTs in the entire mouse GenBank database. Genes with moderate and low expression levels were cytoplasmic ribosomal proteins and are designated. Those with background signal levels were mitochondrial ribosomal protein genes and are Mrpl10, Mrpl51, Mrps9, Mrps16, and Mrps19a. labeling and hybridization. The cutoff point can be estimated using spike controls (Badiee et al. 2003) , which requires a great deal of planning, effort, and validation. Instead, we propose utilizing genes for ribosomal protein cDNAs present on the array as an internal standard. These genes were chosen because there are a relatively large number of them, and, for the most part, they are ubiquitously expressed. In addition, the mitochondrial ribosomal protein transcripts are considered to be rare transcripts. We found that the ribosomal protein gene expression levels could be used as an additional internal standard for estimating relative transcript frequency levels (Fig. 3) . Interestingly, the relative expression levels observed in the microarray corresponded, in general, to the number of sequences of each of the ribosomal protein EST identified in the GenBank database. It must be recognized that their expression levels may vary among the different cell and tissue types, but their relative expression levels should not vary when comparing similar cellular or tissue samples. These factors also enable one to set up a QPCR standard curve to quantify expression levels of genes on the array based on their intensity levels. Genes for ribosomal proteins can also provide a good measure of overall assay sensitivity by comparing the intensity levels observed in any microarray experiment (Fig. 3) . However, it is important that the lack of significant hybridization signal in our studies should not be taken to mean that there is no gene expression because the expression levels may be below the level of detection relative to other lowfrequency transcripts.
Differential expression analyses
For each comparison, locally weighted normalization produced at least 12 log-transformed values (4 hybridizations multiplied by 3 spots per slide) for every cDNA represented (see Fig. 4 ). These values were input into the SAM program and used to generate plots that determined which genes were significantly differentially expressed. Figure 5 shows SAM plots for each of the three comparisons. The delta values were adjusted to minimize the number of false positives while maximizing biological significance. The median false significant values were less than 0.5, indicating that our data are reliable. In each case, slightly more than 200 genes were characterized as differentially expressed. However, this included genes that were represented on the array more than once. The number of unique genes characterized as differentially expressed was around 150 for each comparison. The OC showed the highest number of unique upregulated genes, followed by the LW, and then the SG. This makes sense considering the source of the cDNA spotted onto the array. In addition, the OC has a larger diversity of cell types and functions compared with the other two tissues.
Genes were identified that showed significantly higher expression in one tissue type compared with the other two. For example, genes upregulated in the OC for both the OC vs. LW and OC vs. SG comparisons were put into a group. We surmised that these genes may play an important functional role in their respective tissues. Table 3 shows the results of these data. Included are normalized SAM scores to compare the relative levels of differential expression. The OC group consists of several genes that do or may play crucial roles in hearing. These include otoancorin , and SG vs. LW (C). For each comparison, the total number significant, median number false significant, and delta value are shown. Significant differentially expressed genes are represented by either green (tissue 1) or red (tissue 2) data points shown outside of the delta cutoff lines. The delta value is set to maximize the significant data points and minimize the false significant.
(Otoa) and transmembrane serine protease 3 (Tmprss3), which are both implicated in autosomal recessive deafness Zwaenepoel et al. 2002) . Also included are otoraplin (Otor), a possible deafness gene associated with the otic capsule (Cohen-Salmon et al. 2000) , and otospiralin (Otos), which leads to hair cell degeneration and deafness in guinea pigs when downregulated (Delprat et al. 2002) . The remaining genes in this group play diverse functional roles in the OC, and many have been shown to be expressed at relatively high levels in the OC compared with surrounding regions. One example is Skp1a, also known as organ of Corti protein 2 (Ocp2), which is part of a novel SCF ubiquitin ligase complex involved in cochlear homeostasis (Liang et al. 1997) .
The SG group consists of a large proportion of myelin-related genes, including Plp, Cnp1, Mal, Mpz, and Fth. There are also a number of genes with other neuronal functions. For example, Ptgds is responsible In the LW set, two major functional groups of genes were identified. The first group is involved in maintaining ion concentration and regulation of fluids within the inner ear. These include Car2, Car14, Slc4a11, Ppp1r1b, and Atp1b3. The second group of genes is involved in cell growth, proliferation, and differentiation. These genes include Tg f br2, Qscn6, and Ndr3. Again, these groups of genes are consistent with our expectations for the LW, which is involved in homeostasis of cochlear fluids and endolymph secretion, among other things. 
DISCUSSION
To expand utilization of global expression analyses, baseline data of the normal relative levels and patterns of gene expression still need to be established for developmental stages and specific regions or cell types of the inner ear. Our custom microarray chip, CMA-IE1, represents an initial attempt at using a microarray designed specifically for the global expression of inner ear genes. cDNAs were primarily obtained from cDNA libraries with~20,000 clones being analyzed Pompeia et al. 2004) , where approximately 2000 transcripts were identified only in the inner ear and likely representing rare to low-frequency inner ear transcripts. These unique ESTs represent 2Y3% of the current mouse transcriptome encyclopedia (Okazaki et al. 2002; Carninci et al. 2003) and are not currently represented by any commercial microarray chip. This microarray increases our chances of finding new or novel genes involved in hearing or in development of the ear. As demonstrated in this study, four differentially expressed genes, Otoa, Otor, Otos, and Tmprss3, were identified that are associated with hearing impairment ( Zwaenepoel et al. 2002) . Although a number of unidentified singletons exhibited differential expression in the LW, OC, or SG, none were found to colocalize with a deafness locus Pompeia et al. 2004 ). Identification of functionally pertinent genes demonstrates the overall utility of the CMA-IE1 chip for further studies in spatiotemporal expression differences in normal and diseased inner-ear end organs, especially considering the representation of a large number of unidentified singletons and clusters. Reduction of the cellular complexity of the compared samples should also facilitate global expression analyses. Our goal is to develop a comprehensive set of transcripts pertaining to the inner ear on the array for identification of gene networks and arrangement of genes into functional clusters. Characterizing such pathways under normal or altered conditions requires the ability to screen many candidate genes simultaneously at different time points and under different experimental conditions. A major hurdle for global expression analyses is the threshold of detection and the sensitivity of the microarray system to discriminate significant changes in expression of rare to low-frequency transcripts. Although a large number of low-frequency genes (10Y25 transcripts/cell) can be detected, a number of inner-ear-pertinent genes are at or below this level of detection. The identification of both rare transcripts at G10 copies per cell and transcripts with limited but restricted expression within the different inner-ear cell types can be masked by assay noise generated by the general population. Limiting the transcript repertoire to a single cell population is a valid approach. However, obtaining a pristine cell population of at least 500 cells represents a technical challenge (Glowatzki et al. 1995; Zheng et al. 2000) and also requires linear amplification of the transcript repertoire. Linear amplification from a small number of cells does result in loss of specificity because of the production of shorter and shorter probes with each round of amplification (Scherer et al. 2003; Wilson et al. 2004 ). Biologically significant changes may still be undetectable by global analyses in the expression levels of inner-ear-pertinent genes. Nevertheless, quantitative PCR analyses for individual genes would be the method of choice to quantify these transcripts (Liberman et al. 2002; Stankovic and Corfas 2003) .
Currently, only limited data are available for comparing our study with other inner-ear microarray studies, which primarily utilize commercially available chips. Expression analyses have been performed with an Atlas expression array (Clontech, Palo Alto, CA) containing 588 cDNAs, using 8-to 12-week-old rat whole cochlea and dissected fractions representing the modulus (MOD) and a combination of organ of Corti and lateral wall (OCYLW) (Cho et al. 2002) . Sixteen differentially expressed genes were observed between rat MOD and OCYLW, and of these, only five genes (P2rx2, Plp, Pmp22, Limk1, and Nnat) were shared in common with our microarray. P2x purinogenic receptor 2 (P2rx2) was expressed at significantly higher levels in the mouse OC and rat OCYLW than in the SG, LW, or MOD. As suggested by immunohistochemical data (Housley et al. 1999; Jarlebark et al. 2002) , this channel is expressed in OHCs, Deiters, and SG type I cells and is upregulated in response to noise (Wang et al. 2003) . The remaining genes are primarily associated with neuronal tissue. We found myelin proteolipid protein (Plp) and neuronatin (Nnat) differentially expressed in the SG, whereas both Pmp22 and Limk1 transcripts were not significantly above background in all three dissected fractions.
Another study used the mouse Mu30K chip (Affymetrix, Santa Clara, CA) to examine differential expression between P2 and P32 mouse whole cochlea (Chen and Corey 2002a,b) . There was little overlap between the Mu30 array and our CMA-IE1 chip. Only three genes could be compared that were developmentally upregulated in adult mice (Chen and Corey 2002a,b) . These were connexin43 (Gja1), a twin-pore potassium ion channel (Kcnk1), and the Na + , K + -activated ATP phosphohydrolase a1 subunit (Atp1a1).
These genes appear to play a role, to varying degrees, in K + recirculation in the inner ear (Estevez et al. 2001; Liu et al. 2001; Wangemann 2002; Nicolas et al. 2003) . We found higher levels of Gja1 transcripts in the SG and LW compared with the OC. This reflects the tissue distribution of connexin43 within the cochlea, in which these channels are mainly localized in the stria vascularis and spiral limbus (a component of the spiral ganglion fraction) (Suzuki et al. 2003; Cohen-Salmon et al. 2004 ). Both ATP1a1 and Kcnk1 (also designated as Twik-1) are ubiquitously expressed in all tissues (Orlowski and Lingrel 1988; Lesage et al. 1997) and are found in the ganglion, vestibular end organs, and the cochlea of the inner ear. However, immunohistochemistry studies have demonstrated that ATP1a1 and Kcnk1 are highly expressed in the marginal and vestibular dark cells. Both these proteins were shown at lower levels in the organ of Corti and spiral ganglion neurons (Zuo et al. 1995; Nicolas et al. 2003) . We found higher levels of both these transcripts in the SG and OC compared with the LW, which does not appear to fit the protein expression patterns. Whole mount in situ hybridization and immunohistochemistry in combination with quantitative RT-PCR should help to resolve these discrepancies between transcript and protein expression levels as well as their associated cellular distribution patterns. Ideally, SAGE analyses (Gunnersen et al. 2002) of dissected cochlear fractions from adult mice should provide a more accurate depiction of the global transcript frequencies in these three fractions. Although these different semiquantitative expression platforms may provide limited comparative data, they still have demonstrated the usefulness of global expression analysis in the inner ear.
Our data demonstrate that differentially expressed genes can be identified among the three cochlear fragments and, in general, reflect their cellular, structural, cytoarchitectural, and functional disparities. Both the SG and LW fractions have a more limited cellular diversity compared with the OC. As noted in differential expression analyses, the cellular diversity is further reflected in the three groups of differentially expressed genes presented in Tables 3Y5. We categorized these genes from their general functional descriptors associated with their Bgene ontology (GO) terms,[ which is based on function, process, and component characteristics of the gene products (Deng et al. 2004; Harris et al. 2004 ). The majority (11/16; 68.8%) of differentially expressed genes in the SG are associated with neuronal tissues with three additional clones, secreted frizzled-related protein 4 (Sfrp4), chemokine ligand 12 (Cycl12), and breast cancer metastasis-suppressor 1-like (Brms1l), representing molecules involved in cellular development and proliferation. In the LW fraction, genes related to ion regulation and transport (8/23; 32%) and those involved in cellular development and proliferation (6/23; 24%) constitute the majority of differentially expressed genes. Both carbonic anhydrase genes (Car2 and Car14) and Na + , K + ATPase (Atp1b3) are all expressed in the lateral wall spiral ligament fibrocytes and are thought to play a role in cochlear fluid and ion homeostasis (Ichimiya et al. 1994; Spicer et al. 1997) . K + homeostasis function of the marginal cells is mediated through the action of membrane proteins, such as Na + , K + ATPases, protein phosphatase inhibitors, and Na + , K + , Cl co-transporters (Zhao et al. 1994; Agrup et al. 1997; Spicer et al. 1997; Delpire et al. 1999; Dixon et al. 1999; Wangemann 2002) . In the LW, we found a differentially expressed subunit of the protein phosphatase 1 regulatory (inhibitor) protein, Ppp1r1b. This gene is likely associated with marginal cells. Another ion transporter, a sodium bicarbonate transporter (Slc4a11), was also identified in the lateral wall. One member of this family of genes, Slc4a7, was found to result in blindness and auditory impairment in mice that carry the targeted disrupted Slc4a7 gene (Bok et al. 2003) and was localized to fibroblasts in the spiral ligament, spiral prominence, and the suprastrial region. The functional properties of the differentially expressed genes associated with the OC were fairly diverse and likely are a reflection of the number and disparity of different cell types within the OC. As such, no one group of genes could be readily identified as being prevalent. To approximate the transcript frequency of the OC differentially expressed genes, we used the frequency of clones derived from the NIH organ of Corti cDNA library. By and large, gene expression levels ranged from moderate [G10% of all the clones: otospiralin (Otos), otoraplin (Otor), and Sphase associated protein 1A (Skp1)], low to moderate [10Y30%: claudin 9 (Cldn9), dermatan sulfate proteoglycan 3 (Gspg3), and gelsolin (Gsn)], and the remainder, which were at a low level of occurrence. OC differentially expressed genes were also represented by three apparently low-frequency transcripts: nonspecific dipeptidase (Cn2) and two hypothetical proteins, MGC58343 and E130318F19Rik. These three genes were identified in the RIKEN subtracted library cDNAs but not in the organ of Corti cDNA clusters ). Thus discrimination of differentially expressed transcripts could be detected regardless of the corresponding frequency.
Although the array was validated through differential expression analyses, detection of cell-unique and rare transcripts is still a major issue and is dependent on the complexity of the sample as well as quantity of starting material necessary for the generation of microarray probes. The small quantities of material obtained from either cells or dissected cochlear tissues necessitate a twofold approach: the amplification of total RNA (Van Gelder et al. 1990; Baugh et al. 2001; Xiang et al. 2003 ) and a signal amplification of fluorescence signals using dendrimer technology (Stears et al. 2000) . Both these strategies were incorporated in our studies. Because of the large number of different cell types and the low percentage of target cell types (e.g., hair cells) within the cochlea, it must be recognized that important rare to low-frequency inner-ear-pertinent transcripts are consequently diluted out in the sample. Methodologies for analysis of small sample sizes, representing single cell to small populations of a single cell type, are still evolving. Because of sampling error, the use of pristine populations of specific cell types is more desirable than single cell samples. Similarly, the statistical methods and approaches for normalization of the raw data and subsequent evaluation of microarray generated data (Tusher et al. 2001; Yang et al. 2002; Dudoit et al. 2003) require sufficient replication, which is difficult with single cell samples.
Microarrays can be used to identify genes that are expressed as well as upregulated or downregulated in the cochlea or its subsections to identify potential candidate deafness genes (Lomax et al. 2000; Chen and Corey 2002a,b; Iijima et al. 2004 ). Studies could also be designed to examine the expression profiles of mutants versus their wild-type counterparts to facilitate the discovery of genes involved in a hearing-related disorder. There are also a wide variety of developmental pathways and gene networks in the ear that could be delineated with microarray studies. Some examples are primary neuron formation and differentiation (Fritzsch and Beisel 2003) and the identification of downstream targets of transcription factors involved in hair cell formation and differentiation (Bryant et al. 2002; Hertzano et al. 2004 ). We will work to continually identify and add genes to the array representing unknown and/or uncharacterized transcripts from cochlear libraries to facilitate studies such as these.
